Literature DB >> 2794055

Inappropriate hepatic cholesterol synthesis expands the cellular pool of sterol available for recruitment by bile acids in the rat.

L E Bilhartz1, D K Spady, J M Dietschy.   

Abstract

These studies test the hypothesis that a major determinant of excessive biliary cholesterol secretion is a level of hepatic sterol synthesis that is inappropriately high relative to the needs of the liver cell for preserving cholesterol balance. Biliary cholesterol secretion was measured in vivo in two models after loading the hepatocyte with sterol by two different mechanisms. In the first model, cholesterol was delivered physiologically to the liver in chylomicron remnants. This resulted in a sixfold increase in cholesteryl ester content and marked suppression of cholesterol synthesis, but biliary cholesterol secretion remained essentially constant. In the second model, 3-hydroxy-3-methyl-glutaryl CoA reductase levels in the liver were markedly increased by chronic mevinolin (lovastatin) administration. Withdrawal of the inhibitor resulted in a sudden fivefold increase in the rate of sterol synthesis in the liver of the experimental animals that was inappropriately high for cellular needs. This excessive synthesis, in turn, was accompanied by a fivefold increase in the cholesteryl ester content, enrichment of microsomal membranes with cholesterol and, most importantly, by a threefold increase in the rate of biliary sterol secretion. As the rate of sterol synthesis gradually returned to normal over 48 h, the cholesterol ester content, the lipid composition of the microsomal membranes, and rate of cholesterol secretion into bile also returned to baseline values. These results further support the concept of functional compartmentalization of cholesterol in the hepatocyte. Derangements that cause an inappropriately high rate of sterol synthesis in the endoplasmic reticulum may lead to an expansion of that pool of cholesterol that is recruitable by bile acids and, hence, to greater situation of the bile.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794055      PMCID: PMC329776          DOI: 10.1172/JCI114283

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  The contribution of newly synthesized cholesterol to biliary cholesterol in the rat.

Authors:  S D Turley; J M Dietschy
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

2.  Measurement of rates of cholesterol synthesis using tritiated water.

Authors:  J M Dietschy; D K Spady
Journal:  J Lipid Res       Date:  1984-12-15       Impact factor: 5.922

3.  Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Authors:  D J Chin; K L Luskey; R G Anderson; J R Faust; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

4.  Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.

Authors:  S M Grundy; D W Bilheimer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Dissociation of hepatic cholesterol synthesis from hepatic low-density lipoprotein uptake and biliary cholesterol saturation in female and male hamsters of different ages.

Authors:  D K Spady; S D Turley; J M Dietschy
Journal:  Biochim Biophys Acta       Date:  1983-10-11

6.  Rates of sterol synthesis and uptake in the major organs of the rat in vivo.

Authors:  S D Turley; J M Andersen; J M Dietschy
Journal:  J Lipid Res       Date:  1981-05       Impact factor: 5.922

7.  Modulation of the stimulatory effect of pregnenolone-16 alpha-carbonitrile on biliary cholesterol output in the rat by manipulation of the rate of hepatic cholesterol synthesis.

Authors:  S D Turley; J M Dietschy
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

8.  Alteration of the degree of biliary cholesterol saturation in the hamster and rat by manipulation of the pools of preformed and newly synthesized cholesterol.

Authors:  S D Turley; D K Spady; J M Dietschy
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

9.  Relationship between hepatic cholesterol synthesis and biliary cholesterol secretion in man: hepatic cholesterol synthesis is not a major regulator of biliary lipid secretion.

Authors:  P N Maton; A Reuben; R H Dowling
Journal:  Clin Sci (Lond)       Date:  1982-05       Impact factor: 6.124

10.  Regulation of rates of cholesterol synthesis in vivo in the liver and carcass of the rat measured using [3H]water.

Authors:  D J Jeske; J M Dietschy
Journal:  J Lipid Res       Date:  1980-03       Impact factor: 5.922

View more
  7 in total

1.  Oral acetylsalicylic acid induces biliary cholesterol secretion in the rat.

Authors:  W F Prigge; R L Gebhard
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.

Authors:  Marleen Schonewille; Jan Freark de Boer; Laura Mele; Henk Wolters; Vincent W Bloks; Justina C Wolters; Jan A Kuivenhoven; Uwe J F Tietge; Gemma Brufau; Albert K Groen
Journal:  J Lipid Res       Date:  2016-06-16       Impact factor: 5.922

3.  Effects of dietary cholesterol and triglycerides on lipid concentrations in liver, plasma, and bile.

Authors:  M L Booker; W W LaMorte; E R Beer; S R Hopkins
Journal:  Lipids       Date:  1997-02       Impact factor: 1.880

4.  Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools.

Authors:  C M Daumerie; L A Woollett; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

5.  The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. off.

Authors:  J H Shand; D W West
Journal:  Lipids       Date:  1995-10       Impact factor: 1.880

6.  The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.

Authors:  J H Shand; D W West
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

7.  Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol.

Authors:  Shi-You Jiang; Hui Li; Jing-Jie Tang; Jie Wang; Jie Luo; Bing Liu; Jin-Kai Wang; Xiong-Jie Shi; Hai-Wei Cui; Jie Tang; Fan Yang; Wei Qi; Wen-Wei Qiu; Bao-Liang Song
Journal:  Nat Commun       Date:  2018-12-03       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.